Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Spinal muscular atrophy with congenital bone fractures 1 - (AR) | 12.5 | | | Thyroid hormone receptor interactor 4
|
|
| | * Muscular dystrophy, congenital Davignon-Chauveau type - MDCD | | * Spinal muscular atrophy with congenital bone fractures 1 - SMABF1 |
|
Spinal muscular atrophy with congenital bone fractures 2 - (AR) | 12.6 | | | Activating signal cointegrator 1 complex subunit 1
|
|
| | * Spinal muscular atrophy with congenital bone fractures 2 - SMABF2 | | * Arthrogryposis related to ASCC1 |
|
Spinal muscular atrophy with progressive myoclonic epilepsy - (AR) | 12.7 | | | N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
|
| | * Spinal muscular atrophy with progressive myoclonic epilepsy - SMAPME |
|
Spinal muscular atrophy and cerebellar hypoplasia - (AR) | 12.8 | | | | * Spinal muscular atrophy and cerebellar hypoplasia |
|
Pontocerebellar hypoplasia, type 1D - (AR) | 12.9 | | | | * Pontocerebellar hypoplasia, type 1D - PCH1D |
|
Spinal Muscular Atrophy type IV related to CAPN1 - (AR) | 12.10 | | | | * Spastic paraplegia 76, autosomal recessive - SPG76 | | * Spinal Muscular Atrophy type IV related to CAPN1 |
|
Scapuloperoneal spinal muscular atrophy - (AD) | 12.11 | | | Transient receptor potential cation channel, subfamily V, member 4
|
|
| | * Scapuloperoneal spinal muscular atrophy - SPSMA | | * Neuronopathy, distal hereditary motor, type VIII - HMN8 | | * Spinal muscular atrophy congenital non progressive of lower limbs - SMAL | | * Spinal muscular atrophy, congenital benin, with contractures - SMAL |
|
Spinal motor neuropathy | 12.12 | | | RNA binding motif protein 7
|
|
| | * Spinal motor neuropathy |
|
Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Neuropathy, distal hereditary motor, autosomal recessive 1 - (AR) | 12.13 | | | Immunoglobulin mu binding protein 2
|
|
| | * Spinal muscular atrophy with respiratory distress - SMARD1 | | * Autosomal recessive CMT axonal type 2S - CMT2S |
|
Neuropathy, distal hereditary motor, autosomal recessive 2 - (AR) | 12.14 | | | Sigma non-opioid intracellular receptor 1
|
|
| | * spinal muscular atrophy, distal, autosomal recessive, 2 - DSMA2 | | * Amyotrophic lateral sclerosis 16, juvenile - ALS16 |
|
Neuropathy, distal hereditary motor, autosomal recessive 3 - (AR) | 12.15 | | | | * spinal muscular atrophy, distal, autosomal recessive, 3 - DSMA3 |
|
Neuropathy, distal hereditary motor, autosomal recessive 4 - (AR) | 12.16 | | | Pleckstrin homology domain containing, family G (with RhoGef domain) member 5
|
|
| | * spinal muscular atrophy, distal, autosomal recessive, 4 - DSMA4 | | * Axonal neuropathy intermediate recessive C - CMTRIC |
|
Neuropathy, distal hereditary motor, autosomal recessive 5 | 12.17 | | | DnaJ (Hsp40) homolog, subfamily B, member 2
|
|
| | * Spinal muscular atrophy, distal related to DNAJB2 | | * Spinal muscular atrophy, distal, autosomal recessive, 5 - DSMA5 | | * Autosomal recessive CMT2 related to DNAJB2 |
|
Neuropathy, distal hereditary motor, autosomal recessive 6 | 12.18 | | | Receptor accessory protein 1(M)
|
|
| | * Neuropathy, distal hereditary motor, autosomal recessive 6 - HMNR6 | | * Distal spinal muscular atrophy, type VB - DSMAVB | | * Spastic paraplegia 31 - SPG31 | | * Neuronopathy, distal hereditary motor, autosomal dominant 12 - HMND12 |
|
Neuropathy, hereditary motor, autosomal recessive 7 - (AR) | 12.19 | | | Von Willebrand factor A domain-containing protein 1
|
|
| | * Neuropathy, hereditary motor, with myopathic features - HMNMYO |
|
Neuropathy, hereditary motor, autosomal recessive 8 - (AR) | 12.20 | | | | * Sorbitol dehydrogenase deficiency with peripheral neuropathy - SORDD | | * Neuropathy, hereditary motor, autosomal recessive 8 - HMNR8 |
|
Neuropathy, distal hereditary motor, autosomal recessive 9 - (AR) | 12.21 | | | | * Coenzyme Q10 deficiency 8 - COQ10D8 | | * Neuropathy, distal hereditary motor, autosomal recessive 9 - HMNR9 |
|
Neuronopathy, distal hereditary motor, autosomal recessive - (AR) | 12.22 | | | Vaccinia related kinase 1
|
|
| | * Pontocerebellar hypoplasia type 1 - PCH1 | | * Complex motor and sensory axonal neuropathy plus microcephaly and cerebral dysge | | * Spinal muscular atrophy, distal, autosomal recessive - DSMA |
|
Neuronopathy, Distal hereditary motor related to HINT1 | 12.23 | | | Histidine triad nucleotide binding protein 1
|
|
| | * Neuromyotonia and axonal neuropathy, autosomal recessive - NMAN | | * Neuronopathy, Distal hereditary motor related to HINT1 |
|
Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Neuronopathy, distal hereditary motor, type I - (AD) | 12.24 | | | | * Neuronopathy, distal hereditary motor, type I - HMN1 |
|
Neuronopathy, distal hereditary motor, autosomal dominant 2 - (AD) | 12.25 | | | Heat shock 27kDa protein 8
|
|
| | * Neuropathy, distal hereditary motor, type II - HMN2A | | * Rimmed vacuole myopathy | | * Charcot-Marie-Tooth neuropathy Type 2L - CMT2L |
|
Neuronopathy, distal hereditary motor, autosomal dominant 3 - (AD) | 12.26 | | | Heat shock 27kDa protein 1
|
|
| | * Charcot-Marie-Tooth neuropathy Type 2F - CMT2F | | * Neuropathy, distal hereditary motor, type IIB - HMN2B |
|
Neuronopathy, distal hereditary motor, autosomal dominant 4 - (AD) | 12.27 | | | Heat shock 27kDa protein 3
|
|
| | * neuronopathy, distal hereditary motor, type IIC - HMN2C |
|
Neuronopathy, distal hereditary motor, autosomal dominant 5 - (AD) | 12.28 | | | | * Neuropathy, distal hereditary motor type V - HMN V | | * Spinal muscular atrophy, distal, type V - DSMAV | | * Charcot-Marie-Tooth disease, axonal, type 2D - CMT2D |
|
Neuronopathy, distal hereditary motor, autosomal dominant 6 - (AD) | 12.29 | | | | * Distal Spinal Muscular Atrophy with Calf Predominance - HMN2D |
|
Neuronopathy, distal hereditary motor, autosomal dominant 7 - (ad) | 12.30 | | | Solute carrier family 5 (sodium/choline cotransporter), member 7
|
|
| | * Neuronopathy, distal hereditary motor, type VIIA, with vocal cord paralysis (Harper-Young) - HMND7 | | * Congenital myasthenic syndrome with episodic apnea - CMS20 |
|
Neuronopathy, distal hereditary motor, autosomal dominant 8 - ( AD) | 12.31 | | | Transient receptor potential cation channel, subfamily V, member 4
|
|
| | * Scapuloperoneal spinal muscular atrophy - SPSMA | | * Neuronopathy, distal hereditary motor, type VIII - HMN8 | | * Spinal muscular atrophy congenital non progressive of lower limbs - SMAL | | * Spinal muscular atrophy, congenital benin, with contractures - SMAL |
|
Neuronopathy, distal hereditary motor, autosomal dominant 9 - (AD) | 12.32 | | | Tryptophanyl-tRNA synthetase
|
|
| | * Neuronopathy, distal hereditary motor, type IX - HMN9 |
|
Neuronopathy, distal hereditary motor, autosomal dominant 10 - (AD) | 12.33 | | | Elastin microfibril interfacer 1
|
|
| | * Neuronopathy, distal hereditary motor, autosomal dominant 10 - HMND10 |
|
Neuronopathy, distal hereditary motor, autosomal dominant 11 - (AD) | 12.34 | | | Spectrin, alpha, nonerythrocytic 1
|
|
| | * Distal motor neuropathy |
|
Neuronopathy, distal hereditary motor, autosomal dominant - (AD) | 12.35 | | | Receptor accessory protein 1(M)
|
|
| | * Neuropathy, distal hereditary motor, autosomal recessive 6 - HMNR6 | | * Distal spinal muscular atrophy, type VB - DSMAVB | | * Spastic paraplegia 31 - SPG31 | | * Neuronopathy, distal hereditary motor, autosomal dominant 12 - HMND12 |
|
Neuronopathy, distal hereditary motor, autosomal dominant 13 - (AD) | 12.36 | | | | * Spastic paraplegia 17 - SPG17 | | * Neuronopathy, distal hereditary motor, autosomal dominant 13 - HMND13 |
|
Neuronopathy, distal hereditary motor, autosomal dominant 14 - (AD) | 12.37 | | | | * Neuronopathy, distal hereditary motor, autosomal dominant 14 - HMND14 | | * Susceptibility to amyotrophic lateral sclerosis related to dynactin 1 |
|
Dominant distal hereditary motor neuropathy - (AD) | 12.38 | | | | * Charcot-Marie-Tooth disease, axonal, type 2N - CMT2N |
|
Hereditary motor and sensory neuropathy V - (AD) | 12.39 | | | | * Hereditary motor and sensory neuropathy V - HMSN5 |
|
Spinal muscular atrophy, lower extremity-predominant, autosomal dominant 1 - (AD) | 12.40 | | | Dynein, cytoplasmic 1, heavy chain 1
|
|
| | * Charcot-Marie-Tooth disease, axonal, type 20 - CMT2O | | * Spinal muscular atrophy, lower extremity, autosomal dominant - SMALED |
|
Spinal muscular atrophy, lower extremity-predominant, autosomal dominant 2A - (AD) | 12.41 | | | Bicaudal D homolog 2 (Drosophila)
|
|
| | * Spinal muscular atrophy, lower extremity, autosomal dominant 2 - SMALED2A | | * Spinal muscular atrophy, lower extremity-predominant, autosomal dominant 2B - SMALED2B | | * Arthrogryposis and BICD2-related neuromuscular disease |
|
Spinal muscular atrophy, lower extremity-predominant, autosomal dominant 2B - (AD) | 12.42 | | | Bicaudal D homolog 2 (Drosophila)
|
|
| | * Spinal muscular atrophy, lower extremity, autosomal dominant 2 - SMALED2A | | * Spinal muscular atrophy, lower extremity-predominant, autosomal dominant 2B - SMALED2B | | * Arthrogryposis and BICD2-related neuromuscular disease |
|
Spinal muscular atrophy, late-onset, Finkel type - (AD) | 12.43 | | | Vesicle-associated membrane protein-associated protein B and C
|
|
| | * Spinal muscular atrophy, late-onset, Finkel type - SMAFK | | * Amyotrophic lateral sclerosis - ALS8 |
|
Spinal muscular atrophy, Jokela type - (AD) | 12.44 | | | Coiled-coil-helix-coiled-coil-helix domain containing 10(M)
|
|
| | * Amyotrophic lateral sclerosis and/or frontotemporal dementia - FTDALS2 | | * late-onset spinal motor neuronopathy, Jokela type - SMAJ |
|
Neuronopathy, Distal hereditary motor related to SYT2 - (AD) | 12.45 | | | | * Myasthenic syndrome, presynaptic, congenital, with or without motor neuropathy - MYSPC | | * Distal motor neuropathy related to SYT2 | | * Myasthenic syndrome, congenital, 7B, presynaptic - CMS7B | | * Myasthenic syndrome, congenital, 7, presynaptic and distal motor neuropathy, autosomal dominant - CMS7A |
|
Neuronopathy, Distal hereditary motor related to GBF1 - (AD) | 12.46 | | | Golgi-specific brefeldin-A resistance factor 1
|
|
| | * Distal hereditary motor neuropathies | | * Charcot-Marie-Tooth disease, dominant intermediate A - CMT2GG |
|
Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Amyotrophic lateral sclerosis 1 (dominant) - (AD) | 12.51 | | | Superoxide dismutase 1, soluble
|
|
| | * Amyotrophic lateral sclerosis 1 - ALS1 | | * Amyotrophic lateral sclerosis, due to SOD1 deficiency - ALS |
|
Amyotrophic lateral sclerosis 1 (recessive) - (AR) | 12.52 | | | Superoxide dismutase 1, soluble
|
|
| | * Amyotrophic lateral sclerosis 1 - ALS1 | | * Amyotrophic lateral sclerosis, due to SOD1 deficiency - ALS |
|
Amyotrophic lateral sclerosis 2 juvenile - (AR) | 12.53 | | | Alsin Rho guanine nucleotide exchange factor 2
|
|
| | * Spastic paralysis, infantile onset ascending - IAHSP | | * Amyotrophic lateral sclerosis, juvenile - ALS2 | | * Primary lateral sclerosis, juvenile - PLSJ |
|
Amyotrophic lateral sclerosis 3 - (AR) | 12.54 | | | | * Amyotrophic lateral sclerosis - ALS3 |
|
Amyotrophic lateral sclerosis 4 - (AD) | 12.55 | | | | * Neuropathy, distal hereditary motor, with pyramidal features - ALS4 | | * Spinocerebellar ataxia, autosomal recessive 1 - SCAR1 | | * Spinocerebellar ataxia with axonal neuropathy type 2 - SCAN2 |
|
Amyotrophic lateral sclerosis 5 - (AD) | 12.56 | | | SPG11 vesicle trafficking associated, Spatacsin
|
|
| | * Spastic paraplegia 11 - SPG11 | | * Charcot-Marie-Tooth neuropathy Type 2X - CMT2X | | * Amyotrophic lateral sclerosis 5 - ALS5 |
|
Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia - (AD) | 12.57 | | | Fusion (involved in t(12;16) in malignant liposarcoma)
|
|
| | * Amyotrophic lateral sclerosis - ALS6 |
|
Amyotrophic lateral sclerosis 7 - (AD) | 12.58 | | | | * Amyotrophic lateral sclerosis - ALS7 |
|
Amyotrophic lateral sclerosis 8 - (AD) | 12.59 | | | Vesicle-associated membrane protein-associated protein B and C
|
|
| | * Spinal muscular atrophy, late-onset, Finkel type - SMAFK | | * Amyotrophic lateral sclerosis - ALS8 |
|
Amyotrophic lateral sclerosis 9 - (AD) | 12.60 | | | | * amyotrophic lateral sclerosis 9 - ALS9 |
|
Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia - (AD) | 12.61 | | | | * amyotrophic lateral sclerosis 10 - ALS10 |
|
Amyotrophic lateral sclerosis 11 - (AD) | 12.62 | | | Sac domain-containing inositol phosphatase 3
|
|
| | * charcot-marie-tooth disease, type 4j - CMT4J | | * Amyotrophic lateral sclerosis 11 - ALS11 |
|
Amyotrophic lateral sclerosis 12, with or without frontotemporal dementia - (AD, AR) | 12.63 | | | | * Amyotrophic lateral sclerosis 12 - ALS12 |
|
Amyotrophic lateral sclerosis 13, susceptibility to - (AD) | 12.64 | | | | * Spinocerebellar ataxia 2 - SCA2 | | * Olivopontocerebellar atrophy II - OPCA | | * Amyotrophic lateral sclerosis 13 - ALS13 |
|
Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia - (AD) | 12.65 | | | Valosin-containing protein
|
|
| | * Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 - IBMPFD1 | | * Inclusion body myopathy with early-onset paget disease and frontotemporal dement - IBMPFD | | * Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia - ALS14 | | * Scapuloperoneal muscular dystrophy and dropped head syndrome | | * Charcot-Marie-Tooth neuropathy Type 2Y - CMT2Y |
|
Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia - (AD) | 12.66 | | | | * Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia - ALS15 |
|
Amyotrophic lateral sclerosis 16, juvenile - (AR) | 12.67 | | | Sigma non-opioid intracellular receptor 1
|
|
| | * spinal muscular atrophy, distal, autosomal recessive, 2 - DSMA2 | | * Amyotrophic lateral sclerosis 16, juvenile - ALS16 |
|
Amyotrophic lateral sclerosis 17 - (AD) | 12.68 | | | Charged multivesicular body protein 2B
|
|
| | * Amyotrophic lateral sclerosis 17 - ALS17 |
|
Amyotrophic lateral sclerosis 18 - (AD) | 12.69 | | | | * Amyotrophic lateral sclerosis 18 - ALS18 |
|
Amyotrophic lateral sclerosis 19 - (AD) | 12.70 | | | V-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 4
|
|
| | * Amyotrophic lateral sclerosis 19 - ALS19 |
|
Amyotrophic lateral sclerosis 20 - (AD) | 12.71 | | | Heterogeneous nuclear ribonucleoprotein A1
|
|
| | * Isolated inclusion body myopathy - IBMPFD3 | | * Amyotrophic lateral sclerosis 20 - ALS20 |
|
Amyotrophic lateral sclerosis 21 - (AD) | 12.72 | | | | * Vocal cord and pharyngeal distal myopathy - VCPDM | | * Familial amyotrophic lateral sclerosis - ALS21 |
|
Amyotrophic lateral sclerosis 22, with or wothout frontotemporal dementia - (AD) | 12.73 | | | | * Amyotrophic lateral sclerosis 22 - ALS22 |
|
Amyotrophic lateral sclerosis 23 - (AD) | 12.74 | | | | * Amytrophic lateral sclerosis 23 - ALS23 | | * Inclusion body myopathy and brain white matter abnormalities - IBMWMA |
|
Amyotrophic lateral sclerosis 24, susceptibility to | 12.75 | | | Never in motosis gene A-related kinase 1
|
|
| | * Amyotrophic lateral sclerosis, susceptibility to, 24 - ALS24 |
|
Amyotrophic lateral sclerosis 25, susceptibility to - (AD) | 12.76 | | | | * Spastic paraplegia 10 - SPG10 | | * CMT2 related to KIF5A | | * Amyotrophic lateral sclerosis 25, susceptibility to - ALS25 |
|
Amyotrophic lateral sclerosis 28 - (AD) | 12.77 | | | Low density lipoprotein receptor-related protein 12
|
|
| | * Oculopharyngodistal myopathy 1 - OPDM1 | | * Amyotrophic lateral sclerosis 28 - ALS28 |
|
Susceptibility to amyotrophic lateral sclerosis related to NEFH - (AD) | 12.78 | | | Neurofilament, heavy polypeptide
|
|
| | * Susceptibility to amyotrophic lateral sclerosis related to NEFH - ALSDC | | * Charcot-Marie-Tooth disease, axonal, type 2CC - CMT2CC |
|
Amyotrophic lateral sclerosis related to peripherin, susceptibility to - (AD) | 12.79 | | | | * Susceptibility to amyotrophic lateral sclerosis related to peripherin |
|
Amyotrophic lateral sclerosis related to dynactin 1, susceptibility to - (AD) | 12.80 | | | | * Neuronopathy, distal hereditary motor, autosomal dominant 14 - HMND14 | | * Susceptibility to amyotrophic lateral sclerosis related to dynactin 1 |
|
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1 - (AD) | 12.81 | | | Chromosome 9 open reading frame 72
|
|
| | * Amyotrophic lateral sclerosis and/or frontotemporal dementia - FTDALS | | * Spinobulbar muscular atrophy (SBMA)
|
|
Frontotemporal dementia and/or amyotrophic lateral sclerosis 2 - (AD) | 12.82 | | | Coiled-coil-helix-coiled-coil-helix domain containing 10(M)
|
|
| | * Amyotrophic lateral sclerosis and/or frontotemporal dementia - FTDALS2 | | * late-onset spinal motor neuronopathy, Jokela type - SMAJ |
|
Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 - (AD) | 12.83 | | | | * Amyotrophic lateral sclerosis and/or frontotemporal dementia - FTDALS3 | | * Myopathy, distal, with rimmed vacuoles - DMRV | | * Welander-like distal myopathy |
|
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 - (AD) | 12.84 | | | | * Amyotrophic lateral sclerosis and/or frontotemporal dementia - FTDALS4 |
|
Amyotrophic lateral sclerosis - (AD) | 12.85 | | | Low Density Lipoprotein Receptor-Related Protein 10
|
|
| | * Amyotrophic lateral sclerosis |
|
Amyotrophic lateral sclerosis - (AD) | 12.86 | | | Serine palmitoyltransferase subunit 1
|
|
| | * Neuropathy, hereditary sensory, type 1 - HSN1 | | * Neuropathy, hereditary sensory and autonomic, type 1 - HSAN1 | | * Amyotrophic lateral sclerosis |
|
Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Lethal Congenital Contracture Syndrome 1 - (AR) | 12.87 | | | GLE1 RNA export mediator homolog (yeast)
|
|
| | * Lethal congenital contracture syndrome 1 - LCCS1 |
|
Lethal Congenital Contracture Syndrome 2 - (AR) | 12.88 | | | V-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)
|
|
| | * Lethal congenital contracture syndrome 2 - LCCS2 |
|
Lethal Congenital Contracture Syndrome 3 - (AR) | 12.89 | | | Phosphatidylinositol-4-phosphate 5-kinase, type I, gamma
|
|
| | * Lethal congenital contractural syndrome 3 - LCCS3 |
|
Lethal Congenital Contracture Syndrome 4 - (AR) | 12.90 | | | Myosin-binding proteinC, slow type
|
|
| | * Arthrogryposis, distal, type 1B - DA1B | | * Lethal Congenital Contracture Syndrome 4 - LCCS4 | | * Congenital myopathy 16 - CMYP16 |
|
Lethal Congenital Contracture Syndrome 5 - (AR) | 12.91 | | | | * Charcot-Marie-Tooth disease, dominant intermediate B - CMTDIB | | * Myopathy centronuclear, 1 - CNM1 | | * Lethal Congenital Contracture Syndrome 5 - LCCS5 |
|
Lethal Congenital Contracture Syndrome 6 - (AR) | 12.92 | | | Zinc finger and BTB domain-containing protein 42
|
|
| | * Lethal Congenital Contracture Syndrome 6 - LCCS6 |
|
Lethal Congenital Contracture Syndrome 7 - (AR) | 12.93 | | | Contactin-Associated Protein 1
|
|
| | * Lethal congenital contracture syndrome 7 - LCCS7 | | * Charcot-Marie Tooth disease related to CNTNAP1 |
|
Lethal Congenital Contracture Syndrome 8 - (AR) | 12.94 | | | | * Lethal Congenital Contracture Syndrome 8 - LCCS8 |
|
Lethal Congenital Contracture Syndrome 9 - (AR) | 12.95 | | | Adhesion G protein-coupled recptor G6
|
|
| | * Lethal Congenital Contracture Syndrome 9 - LCCS9 |
|
Lethal Congenital Contracture Syndrome 10 - (AR) | 12.96 | | | Never in mitosis gene A-related kinase 9
|
|
| | * Lethal Congenital Contracture Syndrome 10 - LCCS10 |
|
Lethal Congenital Contracture Syndrome 11 - (AR) | 12.97 | | | | * Lethal Congenital Contracture Syndrome 11 - LCCS11 |
|
Lethal Congenital Contracture Syndrome related to TTN - (AR) | 12.98 | | | | * Hereditary myopathy with early respiratory failure - HMERF | | * Cardiomyopathy, familial hypertrophic, 9 - CMH9 | | * Congenital myopathy with fatal cardiomyopathy | | * Cardiomyopathy, dilated, 1G - CMD1G | | * Centronuclear myopathy related to TTN | | * LGMDR10 (Formerly LGMD2J) | | * Lethal Congenital Contracture Syndrome related to TTN | | * Congenital myopathy 5 with cardiomyopathy (formerly Salih myopathy) - CMYP5 (SALMY) | | * Autosomal dominant myopathy with proximal muscle weakness and early respiratory | | * Tibial muscular dystrophy, tardive - TMD | | * Limb girdle muscular dystrophy 2J (autosomal recessive) - LGMD2J |
|
Spinal muscular atrophy with pontocerebellar hypoplasia, type 1b - (AR) | 12.99 | | | | * Spinal muscular atrophy with pontocerebellar hypoplasia, type 1b - PCH1B |
|
Spinal muscular atrophy with pontocerebellar hypoplasia - (AR) | 12.100 | | | Vaccinia related kinase 1
|
|
| | * Pontocerebellar hypoplasia type 1 - PCH1 | | * Complex motor and sensory axonal neuropathy plus microcephaly and cerebral dysge | | * Spinal muscular atrophy, distal, autosomal recessive - DSMA |
|
Pontocerebellar hypoplasia with spinal muscular atrophy - (AR) | 12.101 | | | solute carrier family 25 member 46(M)
|
|
| | * Neuropathy, hereditary motor and sensory, type VIB - HSMN6B |
|
Brown-Vialetto-van Laere syndrome 1 - (AR) | 12.102 | | | Solute carrier family 52, riboflavin transporter, member 3
|
|
| | * Brown-Vialetto-Van Laere syndrome 1 - BVVLS1 |
|
Brown-Vialetto-van Laere syndrome 2 - (AR) | 12.103 | | | Solute carrier family 52, riboflavin transporter, member 2
|
|
| | * Brown-Vialetto-Van Laere syndrome 2 - BVVLS2 |
|
Late onset spinal muscular atrophy related to HEXB - (AD) | 12.104 | | | | * Late onset spinal muscular atrophy related to HEXB |
|
Spinal muscular atrophy, related to PRUNE1 - (AR) | 12.105 | | | Prune exopolyphosphatase 1
|
|
| | * Spinal muscular atrophy, related to PRUNE1 |
|
Spinal muscular atrophy with pontocerebellar hypoplasia related to KIF26B - (AD) | 12.106 | | | Kinesin family member 26B
|
|
| | * Spinal muscular atrophy with pontocerebellar hypoplasia related to KIF26B |
|
Peripheral neuropathy, myopathy, hoarseness and hearing loss - (AD) | 12.107 | | | Myosin, heavy chain 14, non muscle
|
|
| | * Peripheral neuropathy, myopathy, hoarseness and hearing loss - PNMHH |
|
Lower motor neuron disease with respiratory failure related to MAPT - (AD) | 12.108 | | | Microtubule associated protein Tau
|
|
| | * Lower motor neuron disease with respiratory failure related to MAPT |
|
Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development - (AR) | 12.109 | | | Minichromosome maintenance 3-associated protein
|
|
| | * Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development - PNRIID | | * Charcot-Marie-Tooth disease, axonal |
|
Inclusion body myopathy and brain white matter abnormalities - (AD) | 12.110 | | | | * Amytrophic lateral sclerosis 23 - ALS23 | | * Inclusion body myopathy and brain white matter abnormalities - IBMWMA |
|
Mitochondrial complex IV deficiency, nuclear type 11 - (AR) | 12.111 | | | Cytochrome c Oxidase Assembly Factor COX20
|
|
| | * Mitochondrial complex IV deficiency, nuclear type 11 - MC4DN11 |
|
Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures - (AR) | 12.112 | | | ADP-Ribosylhydrolase-Like 2
|
|
| | * Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures - CONDSIAS |
|
Spinobulbar muscular atrophy (SBMA) - (AD) | 12.113 | | | Chromosome 9 open reading frame 72
|
|
| | * Amyotrophic lateral sclerosis and/or frontotemporal dementia - FTDALS | | * Spinobulbar muscular atrophy (SBMA)
|
|